Arkolith/Insider Trading/SYRE/Form 4

Fairmount Funds Management LLC

DirectorSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed Jun 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$399.7M
Net Open-Market Flow
-$399.7M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Conversion(C)667K——4.7M
Jun 23, 2026Sell(S)4.7M$85.31$399.7M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 23, 2026Conversion(C)17K—$00

Transaction Codes

C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-076967) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML